BioSpace News Archive

Connecting with patients to participate in device tracking enables them to be contacted in the event of a safety issue There is no additional safety information being communicated beyond the original July 2019 BIOCELL® recall [01-June-2020] IRVINE, Calif. , June 1, 2020 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), is initiating a new di

The first patients were treated as part of a clinical trial testing whether an antibody therapy can safely reduce COVID-19 disease severity. T

Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation therapies that target genetic drivers of cancer, today announced that President and CEO Athena Countouriotis, M.D., will participate via webcast in a question and answer session at the 41st annual Goldman Sachs Global Healthcare Conference on June 9.

SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced its first international delivery of TPOXX® (tecovirimat), with 2,500 courses delivered to the Canadian Department of National Defence (CDND). On April 3, 2020, the Company previously announced that the CDND is expected to purchase u

Anatomage Inc, a market leader in 3D medical imaging technology, announces the launch of Anatomage Table Companion - an iPad app that complements the Anatomage Table experience by allowing users to access one of the Table’s real human cadavers.

The Larvol Group, a Software as a Service (SaaS) company with 125 employees, announced the launch of Veri, their new decision support and competitive intelligence tool during the 2020 ASCO Annual Meeting. The Veri platform offers access to a knowledgebase for predictive biomarkers in oncology and is free for non-commercial use. “Veri is an extremely ambitious project and our focus is to move beyond the capabilities of

Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that Douglas J. Batdorff has joined the Company as Vice President of Manufacturing Operations. Mr. Batdorff will have responsibility for all of Kewaunee’s domestic manufacturing operations.

An emerging surgical technique added to the standard anterior cruciate ligament reconstruction in high-risk adolescent athletes resulted in zero re-tears and zero graft failures after a minimum follow-up of two years, according to preliminary results from patients who were treated at Hospital for Special Surgery.

Sexton Biotechnologies has announced a new solution for biotech manufacturing companies looking for flexible automation options.

Junshi Biosciences (HKEK: 1877), a China-based biopharmaceutical company specializing in discovery, development and commercialization of novel therapies, and Merck, a world leading science and technology company, today announced their collaboration on a clinical trial program designed to investigate the efficacy and safety of anti-PD-1 mAb toripalimab